Mathis on Twitter: "Congrats to medpex Versandapotheke and DocMorris & Zur Rose Group. All the best for this new growth chapter!! 🚀🔥👍 Great work by the entire transaction team 🙏💪 #Deals #Disruption #
![Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity](https://valueandopportunity.files.wordpress.com/2019/03/csm_zurrosegroupfinal_01_70165d445d.jpg?w=860)
Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
![Zur Rose's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile Zur Rose's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/logo/zur-rose-group_owler_20211209_110453_original.png)
Zur Rose's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
![ZUR ROSE GROUP STRENGTHENS EUROPEAN MARKET LEADERSHIP THROUGH ACQUISITION OF MAIL-ORDER AND DIABETES ACTIVITIES OF APOTAL GROUP - ACXIT Capital Partners ZUR ROSE GROUP STRENGTHENS EUROPEAN MARKET LEADERSHIP THROUGH ACQUISITION OF MAIL-ORDER AND DIABETES ACTIVITIES OF APOTAL GROUP - ACXIT Capital Partners](https://www.acxit.com/en/wp-content/uploads/2020/06/2020_06_Zur-Rose_Apotal-.jpg)